Page 8 - 2021 Winter CMTA Report

Two New Members Join Advisory Board
The CMTA welcomed two new members to its Advisory Board
in 2020, part of its mission to provide enhanced expertise in
a wide variety of fields to the community.
Christine Murray, MD
Teresa Carroll, MS, PhD
8 THE CMTA REPORT WINTER 2021
CHRISTINE MURRAY, MD, is a board-certified reproductive
endocrinologist and infertility (REI) specialist. She specializes in in vitro
fertilization and polycystic ovary syndrome with a special interest in
preimplantation genetic testing of embryos, a technology that helps
families deal with genetically inherited disorders and offers an
approach to building families with an increased knowledge of, and
options to address, genetically inherited syndromes.
She has spent 20 years in Vermont as an academic physician
involved with the training of medical students, residents and fellows.
After medical school at the Mayo Graduate School of Medicine, she
underwent OB/GYN residency training at McGill University in Montreal,
Quebec, followed by a fellowship in reproductive endocrinology and
infertility. From 1999-2014, Dr. Murray worked at the University of
Vermont Medical Center and was an associate professor in the
Division of Reproductive Endocrinology. In addition to a busy clinical
practice, Dr. Murray became residency program director in 2004 and
held that position for eight years. In 2015, Dr. Murray opened
Northeastern Reproductive Medicine to bring affordable, comfortable
fertility care to patients wishing to build their families.
Dr. Murray became interested in the CMT community through her
close friendship with the Ouellette family, who started the Vermont
Cycle (and Walk) for CMT. She is interested in helping families
understand their reproductive options and hopes that her extensive
connections within the reproductive medicine community can provide
answers and assistance.
TERESA CARROLL, MS, PHD, is an organismal biologist with
more than 25 years of experience in higher education, primarily as an
associate professor of biology in Missouri. In 2016, she moved to
South Carolina, where she continued teaching at a small regional
university and is currently writing topic-specific manuals for use in
undergraduate biological labs.
Diagnosed with CMT1X in 1994, Teresa is an advocate and
long-time supporter of the CMTA and has spent many hours since her
diagnosis studying the scientific literature on CMT1X in an effort to
understand her condition. Given that her career included taking com-
plex biological information and making it comprehensible for
undergraduate biology majors, Teresa is excited to have the opportu-
nity to use those skills to build patient-friendly communications that
help her fellow CMT patients and their families better understand
the disease. k